Drug intelligence / Profile preview

Vetropolycin HC

Development stage
Unknown
Lead developer
Dechra Veterinary Products
Modality
Small Molecules
Administration
Ophthalmic, Topical
01

Overview

Vetropolycin HC is a veterinary ophthalmic ointment developed by Dechra Veterinary Products for topical ocular treatment of bacterial infections and associated inflammation in dogs and cats. It is a fixed-dose combination of three **small molecule** antibiotics\u2014bacitracin zinc, neomycin sulfate, and polymyxin B sulfate\u2014plus the corticosteroid hydrocortisone acetate. Bacitracin primarily disrupts bacterial cell wall synthesis in susceptible gram-positive organisms, neomycin is an aminoglycoside that inhibits bacterial protein synthesis through ribosomal binding, and polymyxin B disrupts the outer membrane of susceptible gram-negative bacteria; hydrocortisone acetate provides local anti-inflammatory glucocorticoid activity. The product is FDA-approved for veterinary use and is indicated for acute or chronic conjunctivitis and superficial infections of the eyelid and conjunctiva caused by organisms susceptible to the included antibiotics.

Brand names
Vetropolycin HC
Other names
bacitracin zinc + neomycin sulfate + polymyxin B sulfate + hydrocortisone acetate
02

Targets

30S A-site (Bacterial ribosomal 30S A-site)UP (Undecaprenyl phosphate)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Vetropolycin HC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vetropolycin HC.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call